Differential responses of pulmonary vascular cells from PAH patients and controls to TNF α and the effect of the BET inhibitor JQ1
Pulmonary arterial hypertension (PAH) encompasses a group of diseases characterized by raised pulmonary vascular resistance, resulting from vascular remodelling and inflammation. Bromodomain and extra-terminal...
Source: Respiratory Research - Category: Respiratory Medicine Authors: Sharon Mumby, Frederic Perros, Julien Grynblat, Gregoire Manaud, Alberto Papi, Paolo Casolari, Gaetano Caramori, Marc Humbert, S. John Wort and Ian M. Adcock Tags: Research Source Type: research
More News: Hypertension | Respiratory Medicine